A388610 Stock Overview
Develops cosmetic, food, and medical materials. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
GFC Life Science Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩12,980.00 |
52 Week High | ₩19,690.00 |
52 Week Low | ₩4,510.00 |
Beta | 0 |
11 Month Change | -13.47% |
3 Month Change | -24.88% |
1 Year Change | 144.91% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 110.49% |
Recent News & Updates
Recent updates
Shareholder Returns
A388610 | KR Chemicals | KR Market | |
---|---|---|---|
7D | -0.08% | 1.7% | 1.1% |
1Y | 144.9% | -34.5% | -4.0% |
Return vs Industry: A388610 exceeded the KR Chemicals industry which returned -34.5% over the past year.
Return vs Market: A388610 exceeded the KR Market which returned -4% over the past year.
Price Volatility
A388610 volatility | |
---|---|
A388610 Average Weekly Movement | 6.9% |
Chemicals Industry Average Movement | 5.3% |
Market Average Movement | 5.7% |
10% most volatile stocks in KR Market | 11.6% |
10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A388610 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A388610's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | n/a | n/a | www.gfcos.co.kr |
GFC Life Science Co., Ltd develops cosmetic, food, and medical materials. The company develops bio-materials in the areas of human bio-technology, bio-phytochemistry, bio-fermentation, unique bio-technology, and biocompatible formula technology. It also offers scientific and systematic research services on human application testing.
GFC Life Science Co., Ltd Fundamentals Summary
A388610 fundamental statistics | |
---|---|
Market cap | ₩43.44b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A388610 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A388610 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A388610 perform over the long term?
See historical performance and comparison